Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 193.00
-1.00 (-0.52%)
Aug 28, 2026, 1:30 PM CST
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 51.38 billion as of August 28, 2026. Its market cap has decreased by -0.57% in one year.
Market Cap
51.38B
Enterprise Value
103.50B
Revenue
28.49B
Ranking
n/a
PE Ratio
13.40
Stock Price
193.00
ChartMarket Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 51.38B, an increase of 459.26%. That is a compound annual growth rate of 15.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 51.38B | -30.96% |
| Dec 31, 2025 | 74.42B | 4.05% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 55.94B |
| Center Laboratories | 25.19B |
| TTY Biopharm Company | 19.37B |
| Synmosa Biopharma | 16.11B |
| ScinoPharm Taiwan | 15.06B |
| YungShin Global Holding | 14.92B |
| Grape King Bio | 13.42B |
| Handa Pharmaceuticals | 12.81B |